These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 31576456)
1. Synthesis, characterization and anticonvulsant activity of new series of N-modified analogues of VV-hemorphin-5 with aminophosphonate moiety. Todorov P; Peneva P; Tchekalarova J; Rangelov M; Georgieva S; Todorova N Amino Acids; 2019 Nov; 51(10-12):1527-1545. PubMed ID: 31576456 [TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant evaluation and docking analysis of VV-Hemorphin-5 analogues. Todorov P; Rangelov M; Peneva P; Todorova N; Tchekalarova J Drug Dev Res; 2019 Jun; 80(4):425-437. PubMed ID: 30681179 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship study on new hemorphin-4 analogues containing steric restricted amino acids moiety for evaluation of their anticonvulsant activity. Todorov P; Peneva P; Tchekalarova J; Georgieva S; Rangelov M; Todorova N Amino Acids; 2020 Oct; 52(10):1375-1390. PubMed ID: 33011823 [TBL] [Abstract][Full Text] [Related]
5. Investigation of the structure-activity relationship in a series of new LVV- and VV-hemorphin-7 analogues designed as potential anticonvulsant agents. Todorov P; Georgieva S; Peneva P; Tchekalarova J Amino Acids; 2022 Feb; 54(2):261-275. PubMed ID: 34978007 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and anticonvulsant activity of new azobenzene-containing VV-hemorphin-5 bio photoswitch. Todorov PT; Peneva PN; Georgieva SI; Tchekalarova J; Vitkova V; Antonova K; Georgiev A Amino Acids; 2019 Mar; 51(3):549-563. PubMed ID: 30604096 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, molecular docking, electrochemical and fluorimetric analysis of new caffeic and cinnamic acid-conjugated hemorphin derivatives designed as potential anticonvulsant and antinociceptive agents. Todorov P; Georgieva S; Peneva P; Nikolov S; Rangelov M; Todorova N; Pechlivanova D; Tchekalarova J Bioorg Chem; 2024 Feb; 143():107063. PubMed ID: 38150935 [TBL] [Abstract][Full Text] [Related]
8. Antinociceptive Effects of VV-Hemorphin-5 Peptide Analogues Containing Amino phosphonate Moiety in Mouse Formalin Model of Pain. Assenov B; Pechlivanova D; Dzhambazova E; Peneva P; Todorov P Protein Pept Lett; 2021; 28(4):442-449. PubMed ID: 32798365 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and nociceptive screening of new VV-hemorphin-5 analogues. Todorov P; Peneva P; Pechlivanova D; Georgieva S; Dzhambazova E Bioorg Med Chem Lett; 2018 Oct; 28(18):3073-3079. PubMed ID: 30078474 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the anticonvulsant effect of novel melatonin derivatives in the intravenous pentylenetetrazol seizure test in mice. Tchekalarova J; Angelova VT; Todorova N; Andreeva-Gateva P; Rangelov M Eur J Pharmacol; 2019 Nov; 863():172684. PubMed ID: 31545983 [TBL] [Abstract][Full Text] [Related]
11. Effect of Tadalafil on Seizure Threshold and Activity of Antiepileptic Drugs in Three Acute Seizure Tests in Mice. Socała K; Nieoczym D; Pieróg M; Wyska E; Szafarz M; Doboszewska U; Wlaź P Neurotox Res; 2018 Oct; 34(3):333-346. PubMed ID: 29427285 [TBL] [Abstract][Full Text] [Related]
12. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Löscher W; Hönack D; Fassbender CP; Nolting B Epilepsy Res; 1991 Apr; 8(3):171-89. PubMed ID: 1907909 [TBL] [Abstract][Full Text] [Related]
13. The mu-opioid receptor-selective peptide antagonists, antanal-1 and antanal-2, produce anticonvulsant effects in mice. Fichna J; Socała K; Nieoczym D; Gach K; Perlikowska R; Janecka A; Wlaź P Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():126-31. PubMed ID: 22918032 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and biological study of new synthetic opioid hemorphin-4 peptides containing sterically restricted nonnatural amino acids. Todorov P; Georgieva S; Trapella C; Chakarov K; Tchekalarova J; Pechlivanova D; Cheshmedzhieva D; Fantinati A; Illuminati D Arch Pharm (Weinheim); 2024 Jul; 357(7):e2400052. PubMed ID: 38578075 [TBL] [Abstract][Full Text] [Related]
15. Excavating precursors from the traditional Chinese herb Polygala tenuifolia and Gastrodia elata: Synthesis, anticonvulsant activity evaluation of 3,4,5-trimethoxycinnamic acid (TMCA) ester derivatives. Zhao Z; Bai Y; Xie J; Chen X; He X; Sun Y; Bai Y; Zhang Y; Wu S; Zheng X Bioorg Chem; 2019 Jul; 88():102832. PubMed ID: 31102809 [TBL] [Abstract][Full Text] [Related]
16. Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives. Abuelizz HA; Dib RE; Marzouk M; Anouar EH; A Maklad Y; N Attia H; Al-Salahi R Molecules; 2017 Jun; 22(7):. PubMed ID: 28665338 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, Molecular Docking and Evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one Derivatives for their Anticonvulsant Activity. Jain N; Jaiswal J; Pathak A; Singour PK Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):63-73. PubMed ID: 28056730 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of anticonvulsant activities of benzoxazole derivatives containing the 1,2,4-triazolone moiety. Song MX; Huang Y; Wang S; Wang ZT; Deng XQ Arch Pharm (Weinheim); 2019 Aug; 352(8):e1800313. PubMed ID: 31330092 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, anticonvulsant activity and molecular modeling study of some new hydrazinecarbothioamide, benzenesulfonohydrazide, and phenacylacetohydrazide analogues of 4(3H)-quinazolinone. Al-Salem HS; Hegazy GH; El-Taher KE; El-Messery SM; Al-Obaid AM; El-Subbagh HI Bioorg Med Chem Lett; 2015 Apr; 25(7):1490-9. PubMed ID: 25754489 [TBL] [Abstract][Full Text] [Related]
20. α-Spinasterol, a TRPV1 receptor antagonist, elevates the seizure threshold in three acute seizure tests in mice. Socała K; Nieoczym D; Pieróg M; Wlaź P J Neural Transm (Vienna); 2015 Sep; 122(9):1239-47. PubMed ID: 25764210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]